All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @jts.p3ps on TikTok · 36s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @jts.p3ps's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00So if you get a tan from MT2, how long is that tanning at the last?
  2. 0:03If someone recently just stopped MT2, let me show you some pictures.
  3. 0:07For some reference, I took a very small dose a couple times a week for two weeks.
  4. 0:11These two photos are the before and after.
  5. 0:13And it has now been a week since I took my last dose MT2.
  6. 0:16I think you can maintain it with no sun for one week.
  7. 0:19Second week after stopping, kind of as where I'm at, starts to come back to normal.
  8. 0:23And then by a month, you're fully back to your original skin tone.
  9. 0:26I feel like I still have the effects of the skin glow that you get from that fresh tan,
  10. 0:30but that could also be GHK-Cu.
  11. 0:32But I'm pretty interested in trying MT1, so if anything, comment down below.

Melanotan II tanning claims: what the science says about duration

JT

TikTok creator

6.4K viewsWatch on TikTok

Quick answer

The creator describes using melanotan II (MT2) at an unspecified low dose twice weekly for two weeks, then tracking pigmentation fade over approximately one month post-cessation. MT2 is a synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanogenesis via MC1R binding and is not FDA-approved for any therapeutic use. The one-month fade timeline they describe is roughly consistent with normal epidermal turnover cycles, but individual variation based on skin type, cumulative UV exposure, and total dose makes this a poor basis for generalized guidance.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Melanotan II tanning claims: what the science says about duration, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

GHK-Cu (Copper Peptide) should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Melanotan II tanning claims: what the science says about duration" from JT. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes using melanotan II (MT2) at an unspecified low dose twice weekly for two weeks, then tracking pigmentation fade over approximately one month post-cessation.

The reason this review is not generic is the source wording and the canonical claim label "peptides how long does the tan from mt2 last bp mt2 skin ghkcu kglow." In this clip, the useful excerpt is: "So if you get a tan from MT2, how long is that tanning at the last?" That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against SCENESSE (afamelanotide implant) FDA Prescribing Information (2019), Afamelanotide for Erythropoietic Protoporphyria (2015), and Melanotan II injection resulting in systemic toxicity and rhabdomyolysis (2012), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The one-month return-to-baseline timeline has some support in clinical pharmacology literature (Dorr et al.
People who land here are usually comparing the GHK-Cu (Copper Peptide) claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GHK-Cu (Copper Peptide) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator describes using melanotan II (MT2) at an unspecified low dose twice weekly for two weeks, then tracking pigmentation fade over approximately one month post-cessation.

FormBlends verdict

GHK-Cu (Copper Peptide) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes using melanotan II (MT2) at an unspecified low dose twice weekly for two weeks, then tracking pigmentation fade over approximately one month post-cessation. MT2 is a synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanogenesis via MC1R binding and is not FDA-approved for any therapeutic use. The one-month fade timeline they describe is roughly consistent with normal epidermal turnover cycles, but individual variation based on skin type, cumulative UV exposure, and total dose makes this a poor basis for generalized guidance.
  • MT2 is not FDA-approved for any use and is sold as an unregulated research chemical, meaning purity and dose accuracy cannot be verified from commercial sources.
  • The one-month return-to-baseline timeline has some support in clinical pharmacology literature (Dorr et al., 2003), but is highly variable based on Fitzpatrick skin type, UV exposure, and cumulative dose.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • MT2 is not FDA-approved for any use and is sold as an unregulated research chemical, meaning purity and dose accuracy cannot be verified from commercial sources.
  • The one-month return-to-baseline timeline has some support in clinical pharmacology literature (Dorr et al., 2003), but is highly variable based on Fitzpatrick skin type, UV exposure, and cumulative dose.
  • Langan et al. (2009, British Journal of Dermatology) reported changes in pigmented lesions in melanotan peptide users, raising a legitimate oncology concern that was absent from this video.
  • Using two compounds simultaneously (MT2 and GHK-Cu) makes it impossible to attribute any aesthetic outcome to either one without a controlled washout period between them.
  • Common MT2 side effects include nausea, flushing, and involuntary erections even at low doses, none of which were mentioned in this video.
  • Normal epidermal turnover runs roughly 28 days, which is the biological basis for any MT2 tan fading within about a month, and makes the creator's rough timeline mechanistically plausible if not precisely accurate.
  • Anyone considering peptides that affect melanocortin receptors should have a baseline dermatological assessment, particularly a mole check, before and after any use period.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @jts.p3ps actually say?

The creator shared a before-and-after personal experiment with melanotan II (MT2), claiming the tan lasts roughly two weeks after stopping use. Their rough timeline: "you can maintain it with no sun for one week," the second week it starts fading, and "by a month, you're fully back to your original skin tone." They also mentioned noticing a skin glow they credited potentially to GHK-Cu rather than MT2 itself, and teased curiosity about melanotan I. The dose was described only as "a very small dose a couple times a week for two weeks." No specific milligram amounts were given, which is about the only responsible part of the framing here.

The video is an n=1 anecdote with photos. That is worth noting upfront. One person's experience with an unregulated, non-FDA-approved peptide is not a clinical finding. But let's at least see how the timeline claim holds up against what researchers have actually measured.

Does the science back this up?

The two-week fade timeline is roughly consistent with what limited research exists, but the creator is presenting personal experience as if it's a predictable rule, which it is not. Melanotan II works by binding melanocortin receptors, primarily MC1R, stimulating melanogenesis. Once dosing stops, melanin production slows and the existing pigment fades through normal skin cell turnover, which runs on a cycle of roughly 28 days.

A 2003 study by Dorr et al. in the Journal of Clinical Pharmacology documented that skin pigmentation from MT2 faded over approximately four weeks post-cessation in fair-skinned individuals, which actually aligns more with the creator's one-month full-return estimate than their two-week maintenance window. The rate of fading varies substantially based on baseline Fitzpatrick skin type, UV exposure during the dosing period, total cumulative dose, and individual melanocyte density. What lasted two weeks for this creator could last three days or six weeks for someone else. Presenting a personal timeline as generalizable guidance is where the video goes wrong.

What did they get wrong (or right)?

They got the rough order-of-magnitude right. A tan from MT2 does not last forever, and the one-month return-to-baseline figure has some support in the literature. Credit where it is due.

But several things here are either incomplete or misleading. First, the creator does not disclose that MT2 is not FDA-approved, is sold as a research chemical, and carries documented safety risks including nausea, spontaneous erections, blood pressure changes, and, critically, reports of melanocytic nevi changes that raise genuine oncology concerns. A 2009 case report by Langan et al. in the British Journal of Dermatology flagged changes in existing moles in users of melanotan peptides. That is not a footnote. That is a serious risk that anyone watching a TikTok about tan duration deserves to hear.

Second, attributing the "skin glow" to GHK-Cu without any mechanism or evidence is speculative. GHK-Cu does have research behind collagen synthesis and wound healing responses, but "skin glow" is not a defined clinical outcome in those studies. Mixing two compounds and guessing which one caused an aesthetic effect is not useful information.

What should you actually know?

MT2 is not a regulated medication. It is not approved by the FDA for any indication. It is frequently sold online as a "research chemical," meaning quality control, purity, and dosing accuracy are entirely unverified. The tan it produces is real, driven by actual melanin stimulation, but so are the side effects. Nausea, facial flushing, and involuntary erections are commonly reported even at low doses. More seriously, there are case reports linking melanotan peptide use to changes in pigmented lesions and at least one published case of melanoma in a user, though causation was not established.

The creator's timeline of "a month to return to normal" is a reasonable rough estimate for someone with lighter skin and a short dosing period. But individual variation is large enough that this number should not be treated as a predictable outcome. Anyone considering this compound should be talking to a physician who can assess their personal Fitzpatrick type, mole history, and cardiovascular baseline, not sourcing protocols from TikTok comment sections.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

JT · TikTok creator

6.4K views on this video

How long does the tan from MT2 last? #bp #mt2 #skin #ghkcu #kglow

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about mt2?

MT2 is not FDA-approved for any use and is sold as an unregulated research chemical, meaning purity and dose accuracy cannot be verified from commercial sources.

What does the video say about the one-month return-to-baseline timeline has some support in clinical pharmacology?

The one-month return-to-baseline timeline has some support in clinical pharmacology literature (Dorr et al., 2003), but is highly variable based on Fitzpatrick skin type, UV exposure, and cumulative dose.

What does the video say about langan et al. (2009, british journal of dermatology) reported changes?

Langan et al. (2009, British Journal of Dermatology) reported changes in pigmented lesions in melanotan peptide users, raising a legitimate oncology concern that was absent from this video.

What does the video say about using two compounds simultaneously (mt2?

Using two compounds simultaneously (MT2 and GHK-Cu) makes it impossible to attribute any aesthetic outcome to either one without a controlled washout period between them.

What does the video say about common mt2 side effects include nausea, flushing,?

Common MT2 side effects include nausea, flushing, and involuntary erections even at low doses, none of which were mentioned in this video.

What does the video say about normal epidermal turnover runs roughly 28 days,?

Normal epidermal turnover runs roughly 28 days, which is the biological basis for any MT2 tan fading within about a month, and makes the creator's rough timeline mechanistically plausible if not precisely accurate.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by JT, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.